PillCam Colon Capsule Endoscopy for Ulcerative Colitis
Launched by SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Nov 4, 2011
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
Symptomatic patients with confirmed ulcerative colitis (UC) were enrolled in this prospective single-center study. No sooner had patients gone through Pillcam colon capsule (PCC) endoscopy solution than they got conventional colonoscopy which is recognized as the "gold standard" examination technique. The extent of mucosal damage and inflammatory lesions during both modalities were recorded for comparison. In addition, the regimen of bowel preparation, completion rate, colonic cleanliness, compliance or adverse events were analyzed.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (aged 18-70)
- • Ulcerative Colitis history
- • Suffering from symptoms such as hematochezia, diarrhea or abdominal pain
- Exclusion Criteria:
- • Patients with a high risk for capsule retention (such as intestinal diverticula, acute abdominal pain without regular defecation indicating intestinal obstruction or a history of abdominal operation or intestinal reconstructed operation),
- • Patients allergic to sodium phosphate or polyethylene glycol (PEG) solution,
- • Patients with a history of Crohn's disease
- • Patients with serious systematic diseases such as congestive heart failure, renal failure or severe liver disease.
About Shanghai Jiao Tong University School Of Medicine
Shanghai Jiao Tong University School of Medicine is a leading academic institution in China, renowned for its commitment to advancing medical research and education. As a prominent clinical trial sponsor, the school leverages its extensive expertise in biomedical sciences and innovative healthcare solutions to conduct rigorous clinical studies aimed at improving patient outcomes. With a focus on collaboration and translational research, the institution fosters partnerships with healthcare providers, industry leaders, and regulatory bodies to ensure the highest standards of scientific integrity and ethical conduct in clinical trials. Through its research initiatives, Shanghai Jiao Tong University School of Medicine strives to contribute significantly to the global medical community and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
zhi zheng Ge, MD. Ph.D
Principal Investigator
Clinical Professor of Gastroenterology Department, Shanghai Renji Hospital; Director, Head of Digestive Endoscopy Department, Shanghai Renji Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials